0001576427-23-000131.txt : 20231109 0001576427-23-000131.hdr.sgml : 20231109 20231109162936 ACCESSION NUMBER: 0001576427-23-000131 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231108 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mesrobian Edmond CENTRAL INDEX KEY: 0001639494 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36153 FILM NUMBER: 231393027 MAIL ADDRESS: STREET 1: 10 S ALMADEN BLVD STREET 2: 16TH FLOOR CITY: SAN JOSE STATE: CA ZIP: 95113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Criteo S.A. CENTRAL INDEX KEY: 0001576427 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311] IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 BUSINESS PHONE: 33175850939 MAIL ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 4 1 wk-form4_1699565360.xml FORM 4 X0508 4 2023-11-08 0 0001576427 Criteo S.A. CRTO 0001639494 Mesrobian Edmond C/O CRITEO LEGAL DEPT. 387 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10016 1 0 0 0 0 Ordinary Shares 2023-11-08 4 A 0 5960 23.50 A 22215 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. /s/ Ryan Damon, as attorney-in-fact for Edmond Mesrobian 2022-11-09